Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells
- PMID: 2665164
Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells
Abstract
Cultured human umbilical vein endothelial cells (HUVEC) have been reported to produce extrinsic pathway inhibitor (EPI), the factor Xa-dependent inhibitor of factor VIIa/tissue factor (TF). We examined the release of this inhibitor from HUVEC as a function of their growth state and in response to the induction of endothelial cell TF activity. HUVEC constitutively produced significant amounts of EPI at all stages of their growth in culture including the post-confluent state. Rate of release varied over a 3-fold range for primary cultures from 12 different batches of pooled umbilical cord cells. Constitutive EPI release was unaltered during a 6 hour period of induction of TF activity with thrombin or phorbol ester but slowed during longer incubation of the cells with phorbol ester. Whereas plasma contains two molecular weight forms of EPI, only the higher of these two molecular weight forms was demonstrable by Western analysis of HUVEC supernatants with 125I-factor Xa as the ligand.
Similar articles
-
Functional properties of factor VIIa/tissue factor formed with purified tissue factor and with tissue factor expressed on cultured endothelial cells.Thromb Haemost. 1989 Dec 29;62(4):1067-73. Thromb Haemost. 1989. PMID: 2617454
-
Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition.Thromb Haemost. 1988 Dec 22;60(3):453-6. Thromb Haemost. 1988. PMID: 3238648
-
The lipoprotein-associated coagulation inhibitor.Prog Hemost Thromb. 1991;10:243-68. Prog Hemost Thromb. 1991. PMID: 2008533 Review.
-
Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol.Blood Coagul Fibrinolysis. 1991 Jun;2(3):425-33. Blood Coagul Fibrinolysis. 1991. PMID: 1932528
-
Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.Haemostasis. 1991;21(4):219-39. doi: 10.1159/000216231. Haemostasis. 1991. PMID: 1794748 Review.
Cited by
-
Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes.Int J Mol Sci. 2024 Apr 3;25(7):3981. doi: 10.3390/ijms25073981. Int J Mol Sci. 2024. PMID: 38612792 Free PMC article. Review.
-
A journey to vasculopathy in systemic sclerosis: focus on haemostasis and thrombosis.Clin Exp Med. 2023 Dec;23(8):4057-4064. doi: 10.1007/s10238-023-01222-x. Epub 2023 Nov 1. Clin Exp Med. 2023. PMID: 37914967 Review.
-
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.Proc Natl Acad Sci U S A. 1990 Nov;87(22):8869-73. doi: 10.1073/pnas.87.22.8869. Proc Natl Acad Sci U S A. 1990. PMID: 2247459 Free PMC article.
-
Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.J Clin Invest. 1991 Nov;88(5):1760-5. doi: 10.1172/JCI115495. J Clin Invest. 1991. PMID: 1939660 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous